1. Studying the antihyperlipidaemic basis of ayurvedic formulations –Avipattikara churna and triphala churna
- Author
-
K. Nagarajan, Kumar Sokindra, and Dixit Praveen K
- Subjects
Traditional medicine ,Cholesterol ,business.industry ,Blood lipids ,Disease ,chemistry.chemical_compound ,chemistry ,Hypolipidemic Agents ,Medicine ,lipids (amino acids, peptides, and proteins) ,General Pharmacology, Toxicology and Pharmaceutics ,Risk factor ,Medicinal plants ,Adverse effect ,business ,Triphala - Abstract
Increased blood lipid profile (hyperlipidaemia) has been described as a significant risk factor, which is majorly responsible for making the coronary heart diseases more severe. Coronary heart disease, stroke, atherosclerosis and hyperlipidaemia are the primary cause of death. The increase in total cholesterol and total low-density lipoprotein (LDL) cholesterol is described for its main risk factor, which is responsible for cardiovascular disease. The anti-hyperlipidemic drugs are used frequently for its lipids lowering potential to protect disorders which are induced by a condition like atherosclerosis. Still, these hypolipidemic agents also have various sorts of adverse events. Many plants and their derivatives and have been tested successfully for their anti-hyperlipidemic role. Almost 70 medicinal plants and more than this have been successfully screened for their significant anti-hyperlipidemic role. The significant increase observed in the use of medicinal plants in metropolitan regions of developed countries in the last decades. There are so many medicinal plants play a crucial role in lowering the blood lipid level. The most important advantage and popularity of traditional medicine system are because of effectiveness, safety, affordability and acceptability. This review focus on the anti-hyperlipidemic role of Avipattikar Churna and Triphala Churna used for the treatment of hyperlipidaemia.
- Published
- 2020